PharmScreen2: Holistic Quantum Mechanics Based Platform to Accelerate Drug Discovery

Image: National Institute of Standards and Technology, public domain, via Wikimedia Commons (licence). Cropped and resized. Image credits

Horizon 2020
1 Sep 2020 to 31 Aug 2022
Spain

Project page and source record Share by email Share on LinkedIn

Participants, websites and capabilities are shown to signed-in members.Sign in or request access

PharmScreen2 is a Horizon 2020 project (call H2020-EIC-SMEInst-2018-2020) coordinated by Pharmacelera SL (Spain). 1 participating organisation(s) in 1 countries. EU maximum contribution EUR 958,703; total cost EUR 1,369,575. Runs 2020-09-01 to 2022-08-31 (status: closed).

Original source.

Source: CORDIS, Publications Office of the European Union (CORDIS). Retrieved 2026-10-16. Licence: European Commission reuse notice (Decision 2011/833/EU). Selected administrative metadata, adapted presentation. No endorsement by the source is implied. Licence: European Commission reuse policy (Decision 2011/833/EU).

AI-assisted summary: PharmScreen2 is a Horizon 2020 project coordinated by Pharmacelera SL in Spain, aimed at accelerating drug discovery. The project ran from September 1, 2020, to August 31, 2022, with a total cost of EUR 1,369,575 and an EU contribution of EUR 958,703. Suggested technology pillar: simulation. Generated by AI from the public source text; it may contain errors and the original source is authoritative.

Source: cordis.europa.eu · checked 16 Oct 2026 · AI-assisted summary

PharmScreen2: Holistic Quantum Mechanics Based Platform to Accelerate Drug Discovery

Publications linked to this grant in the OpenAIRE Graph